The National Agency for Food and Drugs Administration and Control (NAFDAC) has alerted the public on the sale of a falsified Paracetamol Injection mislabelled as Paracetamol Injection 300mg/2ml I.M I.V Aminoglycoside Antibacterial.
A statement released by the agency says the product was discovered during a surveillance activity carried out by the post-marketing surveillance (PMS) unit of the Agency in FCT, Abuja.
‘’The falsified product was sampled for laboratory analysis and the result of analysis conducted on the product by NAFDAC Laboratory Kaduna showed that the product contained only paracetamol.”
Paracetamol Injection is an analgesic and antipyretic used to treat mild to moderate pain and to reduce fever. It is not an Aminoglycoside Antibacterial as labeled on the product.
Aminoglycosides are a class of antibiotics used to treat serious infections caused by bacteria that are difficult to treat.
The statement adds that all NAFDAC zonal directors and state coordinators have been directed to carry out surveillance and mop up the falsified product within the zones and states.
‘’Importers, distributors, retailers, healthcare professionals, and caregivers are hereby advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of the falsified product.
“All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked,” the statement reads partly.
The statement also advised healthcare professionals and consumers to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, or call NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng.
